Anchor Pharma Private Limited, a active private limited company, was established on 28 April 1975 in Daman, Daman And Diu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232DD1975PTC000218. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Employing 52 professional, Its leadership includes Kunal Mukesh Mehta (Director), Meenaxi Mukesh Mehta (Director Appointed In Casual Vacancy). Past directors included Jayantilal Raichand Mehta. It holds ₹4.93 Cr open charges and ₹3.06 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-6 Omnibus Industrialdevelopment Corporation Ringanwada, Daman, Daman And Diu, 396210.
U24232DD1975PTC000218
000218
28 April 1975
₹2.50 M
₹2.00 M
Roc Goa
Unlisted
Active
Explore comprehensive insights into Anchor Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Mukesh Mehta | Director | 16 Aug 2001 | Current |
| Meenaxi Mukesh Mehta | Director Appointed In Casual Vacancy | 11 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Dec 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anchor Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.07% increase. The company also saw a slight decrease in profitability, with a 0.86% decrease in profit. The company's net worth moved up by a moderate rise of 8.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Anchor Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹49,300,000.00
₹30,624,301.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 May 2024 | Others | ₹3.80 Cr | Open |
| 04 Jan 2023 | Others | ₹1.30 M | Open |
| 29 Jun 1991 | Canara Bank | ₹1.00 Cr | Open |
| 01 Apr 2000 | The Hongkong & Shanghai Banking Corporation Ltd. | ₹0.32 M | Satisfied |
| 02 Jun 1999 | Others | ₹3.03 Cr | Satisfied |
Explore comprehensive loan charge details -
Anchor Pharma has a workforce of 52 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Anchor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anchor Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Anchor Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Anchor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Goa. was documented.
Progress on A charge with Others of Rs. 38.00 M registered on 22 May 2024 with Charge ID 100928500 was modified on 25 Feb 2025. was documented.
A charge with Others amounted to Rs. 38.00 M with Charge ID 100928500 was registered on 22 May 2024. was recorded as a recent event.
A charge registered on 02 Jun 1999 via Charge ID 90384075 with Others was fully satisfied on 13 Mar 2024. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.30 M with Charge ID 100692122 was registered on 04 Jan 2023. was documented.
The CIN of Anchor Pharma Private Limited is U24232DD1975PTC000218.
Anchor Pharma Private Limited is headquartered at B-6 Omnibus Industrialdevelopment Corporation Ringanwada, Daman, Daman And Diu, 396210.
Anchor Pharma Private Limited was incorporated on 28 April 1975.
The current directors of Anchor Pharma Private Limited are
The primary industry of Anchor Pharma Private Limited is Manufacturing.
Anchor Pharma Private Limited is unlisted.
The authorized capital of Anchor Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.00 M.
The compliance status of Anchor Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX